Has there been a recall of Zofran from the market?
In 2012, the FDA issued a partial recall of Zofran. Specifically, it recalled the 32 mg intravenous version. It did so because taking this form of the medication could increase the risk of QT interval prolongation, which is an irregular heartbeat that can have fatal implications. However, it did not recall the oral versions of Zofran or the smaller, .15mg intravenous version of Zofran. Interestingly, the FDA acknowledged that the 32 mg intravenous form of Zofran would not be completely taken out of the market until early 2013 due to distribution cycles. Also, it encouraged doctors and patients to report side effects related to Zofran to them.
For additional information, see the following pages:
- Are there any time constraints for pursuing a lawsuit related to Zofran-birth-defects?
- What must be alleged in a Zofran lawsuit in Federal Court?
- What damages are available for myself and my child in a Zofran birth defect lawsuit?